BRR : 10787955
Tender Brief : Supply 187 Anti Cancer (Generic / Innovator On Demand) Drugs On Rate Contract Basis To Rcc Supply 187 Anti Cancer (Generic / Innovator On Demand) Drugs On Rate Contract Basis To Regional Cancer Centre,Thiruvananthapuram , Abiraterone Tab Ip, 250 Mg , Actinomycin D Inj, 0.5Mg/3Ml , Amifostine For Inj Usp, 500Mg , Anastrazole Tab Ip, 1Mg , Arsenic Trioxide Inj, 10 Mg , Axitinib Tab, 5 Mg , Azacitidine Inj, 100 Mg , Azacitidine Tab, 300 Mg , Bendamustine Inj Ip, 100Mg , Bevacizumab Inj., 100Mg , Bicalutamide Tab Ip, 50Mg , Bleomycin Inj Ip, 15 Units , Bortezomib Inj Ip, 2Mg , Busulphan Inj, 60 M... Read More
Tender Value
₹
Ref. Document
Contract Value
₹ 43,90,55,709.5
Submission Date
23-05-2025
Contract Date
03-02-2026
Completion Date
365 days
Participated Bidder List
36 No of Bidder(s)
| Sr No. | Bidder Name | Bid Analytics | Technical Bid | Financial Bid | AOC | Bid Value | Rank |
|---|---|---|---|---|---|---|---|
| 1 | cnet-technologies | Bid Analytics | L1 | ||||
| 2 | cnet-technologies | Bid Analytics | L1 | ||||
| 3 | cnet-technologies | Bid Analytics | L1 | ||||
| 4 | cnet-technologies | Bid Analytics | L1 | ||||
| 5 | cnet-technologies | Bid Analytics | |||||
| 6 | cnet-technologies | Bid Analytics | |||||
| 7 | cnet-technologies | Bid Analytics | 1,21,60,960 | L1 | |||
| 8 | cnet-technologies | Bid Analytics | 3,29,00,000 | L1 | |||
| 9 | cnet-technologies | Bid Analytics | 1,33,12,000 | L1 | |||
| 10 | cnet-technologies | Bid Analytics | 13,20,000 | L1 | |||
| 11 | cnet-technologies | Bid Analytics | 1,93,40,000 | L1 | |||
| 12 | cnet-technologies | Bid Analytics | 14,40,000 | L1 | |||
| 13 | cnet-technologies | Bid Analytics | 2,70,630 | L1 | |||
| 14 | cnet-technologies | Bid Analytics | 23,50,350 | L1 | |||
| 15 | cnet-technologies | Bid Analytics | 10,00,000 | L1 | |||
| 16 | cnet-technologies | Bid Analytics | 34,95,425 | L1 | |||
| 17 | cnet-technologies | Bid Analytics | 2,76,69,375 | L1 | |||
| 18 | cnet-technologies | Bid Analytics | 3,95,04,000 | L1 | |||
| 19 | cnet-technologies | Bid Analytics | 2,19,51,448.5 | L1 | |||
| 20 | cnet-technologies | Bid Analytics | 1,39,10,430 | L1 | |||
| 21 | cnet-technologies | Bid Analytics | 6,69,600 | L1 | |||
| 22 | cnet-technologies | Bid Analytics | 2,37,16,515 | L1 | |||
| 23 | cnet-technologies | Bid Analytics | 2,38,62,400 | L1 | |||
| 24 | cnet-technologies | Bid Analytics | 1,72,80,000 | L1 | |||
| 25 | cnet-technologies | Bid Analytics | 33,48,000 | L1 | |||
| 26 | cnet-technologies | Bid Analytics | 27,56,660 | L1 | |||
| 27 | cnet-technologies | Bid Analytics | 25,74,280 | L1 | |||
| 28 | cnet-technologies | Bid Analytics | 3,91,300 | L1 | |||
| 29 | cnet-technologies | Bid Analytics | 81,23,500 | L1 | |||
| 30 | cnet-technologies | Bid Analytics | 2,42,51,000 | L1 | |||
| 31 | cnet-technologies | Bid Analytics | 3,96,96,650 | L1 | |||
| 32 | cnet-technologies | Bid Analytics | 87,60,006 | L1 | |||
| 33 | cnet-technologies | Bid Analytics | 29,14,000 | L1 | |||
| 34 | cnet-technologies | Bid Analytics | 14,22,900 | L1 | |||
| 35 | cnet-technologies | Bid Analytics | 1,26,50,980 | L1 | |||
| 36 | cnet-technologies | Bid Analytics | 7,60,13,300 | L1 |
Work Detail
supply 187 anti cancer (generic / innovator on demand) drugs on rate contract basis to rcc supply 187 anti cancer (generic / innovator on demand) drugs on rate contract basis to regional cancer centre,thiruvananthapuram , abiraterone tab ip, 250 mg , actinomycin d inj, 0.5mg/3ml , amifostine for inj usp, 500mg , anastrazole tab ip, 1mg , arsenic trioxide inj, 10 mg , axitinib tab, 5 mg , azacitidine inj, 100 mg , azacitidine tab, 300 mg , bendamustine inj ip, 100mg , bevacizumab inj., 100mg , bicalutamide tab ip, 50mg , bleomycin inj ip, 15 units , bortezomib inj ip, 2mg , busulphan inj, 60 mg , cabazitaxel inj, 60 mg with codon set , calcium leucovorin tab, 15 mg , capecitabine tab ip, 500mg , carfilzomib inj., 60mg , carmustine inj ip/usp, 100 mg , ceritinib cap, 150 mg , chlorambucil tab ip, 2mg , crizotinib cap, 250 mg , cyclophosphamide tab ip, 50mg , dacarbazine inj ip/usp, 200mg , daunorubicin inj ip, 20mg , decitabine inj, 50 mg , denosumab inj, 120mg , doxorubicin liposomal inj, 20mg , enzalutamide cap, 40 mg , eribulin inj, 0.88 mg/ml , erlotinib tab ip, 100mg , erlotinib tab ip, 150mg , etoposide cap ip, 50mg , etoposide inj ip, 100mg , everolimus tab, 5mg , exemestane tab, 25mg , filgrastim inj, 300 mcg (pfs) , filgrastim inj, 300 mcg (vial) , fludarabine phosphate inj ip / usp, 50mg , fludarabine tab, 10 mg , fulvestrant inj, 250mg , gefitinib tab ip, 250mg , hydroxy urea cap ip, 500mg , ibandronate tab, 150mg , ibandronate tab, 50mg , ibrutinib cap 140mg , idarubicin inj, 5 mg , lapatinib tab ip, 250mg , lenalidomide cap, 10mg , letrozole tab ip/usp, 2.5mg , lomustine cap ip, 40mg , megestrol acetate tab ip, 40 mg , melphalan inj ip, 50mg , melphalan tab, 5mg , mercaptopurine tab ip, 10 mg , mercaptopurine tab ip, 50 mg , mesna inj, 200mg , methotrexate inj ip, 50mg , methotrexate tab ip, 2.5mg , mitomycin inj ip, 10mg , mitoxantrone infusion bp/usp, 20mg , nilotinib cap, 200 mg , octreotide depot inj, 20mg , octreotide depot inj, 30mg , octreotide inj, 100 mcg/ml , olaparib tab, 150 mg , osimertinib tab, 80 mg , pazopanib tab, 400 mg , pegfilgrastim inj, 6mg , peg-l-asparaginase inj 750 iu/ml , pertuzumab inj, 420 mg , procarbazine hcl cap ip, 50mg , protein bound paclitaxel inj, 100mg , rasburicase inj 1.5mg , regorafenib tab 40mg , sorafenib tosylate tab ip, 200mg , tamoxifen tab ip, 20mg , tegafur +uracil cap, 100mg + 224mg , thalidomide cap 100mg , topotecan inj ip, 2.5mg , trabectedin inj, 1 mg , tretinoin cap, 10 mg , vinblastine sulphate inj ip, 10mg , vincristine sulphate inj ip/usp, 1mg , vinorelbine inj ip, 50mg , zoledronic acid inj ip, 4mg , 13-cis-retinoic acid cap, 10 mg , 13-cis-retinoic acid cap, 20 mg , 13-cis-retinoic acid cap, 40 mg , afatinib tab, 30 mg , afatinib tab, 40 mg , calcium leucovorin inj ip, 15mg , calcium leucovorin inj ip, 50mg , carboplatin inj ip, 150mg , carboplatin inj ip, 450mg , cisplatin inj ip, 10mg , cisplatin inj ip, 50mg , cyclophosphamide inj ip, 200mg , cyclophosphamide inj ip, 500mg , cytarabine inj ip/bp, 1 gm , cytarabine inj ip/bp, 100mg , dasatinib tab, 20mg , dasatinib tab, 50mg , docetaxel inj ip, 120mg , docetaxel inj ip, 20mg , docetaxel inj ip, 80mg , doxorubicin inj (lyophilised) ip, 10mg , doxorubicin inj (lyophilised) ip, 50mg , epirubicin inj bp/usp, 10mg , epirubicin inj bp/usp, 50mg , flurouracil inj ip, 250mg , flurouracil inj ip, 500mg , gemcitabine inj ip, 200mg , gemcitabine inj ip, 1gm , ifosfamide with mesna inj, 1gm , ifosfamide with mesna inj, 2gm , imatinib tab ip, 100mg , imatinib tab ip, 400 mg , irinotecan inj ip, 100mg , irinotecan inj ip, 40mg , l.asparaginase inj, 10000 iu , leuprolide acetate inj, 11.25mg , leuprolide acetate inj, 22.5mg , leuprolide acetate inj, 3.75mg , methotrexate inj ip, 1 gm , methotrexate inj ip, 500 mg , oxaliplatin inj ip, 100mg , oxaliplatin inj ip, 50mg , paclitaxel inj ip, 30mg , paclitaxel inj ip with codon set, 100mg , paclitaxel inj ip with codon set, 260mg , pemetrexed inj ip, 100mg , pemetrexed inj ip., 500mg , pomalidomide cap, 2 mg , pomalidomide cap, 4 mg , rituximab inj, 500mg , rituximab inj., 100mg , sunitinib cap, 25 mg , sunitinib cap, 50 mg , temozolomide cap ip, 100mg , temozolomide cap ip, 20mg , temozolomide cap ip, 250mg , trastuzumab emtansine 100mg , trastuzumab emtansine 160mg , trastuzumab inj, 150 mg , trastuzumab inj., 440mg , degarelix inj, 120 mg , degarelix inj, 80 mg , lenvatinib cap, 10 mg , lenvatinib cap, 4 mg , palbociclib tab, 100 mg , palbociclib tab, 125 mg , palbociclib tab, 75 mg , abemaciclib tab 150 mg , alectinib tab, 150 mg , alpelisib tab 150 mg , atezolizumab inj, 1200 mg/ 20ml , bevacizumab inj, 100mg , capecitabine tab ip, 500mg , cetuximab inj, 100mg , cladribine inj, 10mg , cytarabine inj ip/bp, 1 gm , cytarabine inj ip/bp, 100mg , daratumumab inj, 100mg/5ml , daratumumab inj, 400mg/20ml , daratumumab inj, 1800mg for subcutaneous , daunorubicin inj ip, 20mg , doxorubicin inj (lyophilised) ip, 10mg , doxorubicin inj (lyophilised) ip, 50mg , goserelin 10.8 mg inj , letrozole tab ip/usp, 2.5mg , nimotuzumab inj, 200 mg , nivolumab inj, 10 mg/ml , nivolumab inj, 40 mg , olaparib tab, 150 mg , osimertinib tab, 80 mg , palbociclib tab, 100 mg , palbociclib tab, 125 mg , panitumumab inj, 100 mg , pembrolizumab inj, 100mg , pertuzumab inj, 420 mg , ramucirumab inj 500mg/5 ml , ribociclib tab, 200 mg , rituximab inj, 100mg , rituximab inj, 500mg , trastuzumab emtansine inj, 100 mg , trastuzumab emtansine inj, 160 mg
View Original Notice/Document
Result Documents
Tender Documents
| Download | File Name | File Description |
|---|---|---|
| Download | 745c50d6-2754-4c2a-8a00-2316f103b986 | financialevaluation notice |
| Download | boqcomparativechart | boq document |
| Download | finance_1243121 | aoc document |
| Download | finsummary_1243121 | aoc document |
| Download | ac0a1f1f-ec32-4382-a8f3-89217e2f5aaf | result notice |
| Download | ACDTNo03forAOC | document |
Disclaimer
We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender
✦ ✦ ✦
Awarded Bidder(s)
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
Similar Tenders Results